Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
140
about 28 days
40–80
1 site in CA
What this study is about
This trial is testing if a supplement called Sabroxy® can improve insulin resistance and thinking skills in adults with mild cognitive impairment and insulin resistance. Participants will take either Sabroxy® or a placebo for 8 weeks, and researchers will measure changes in insulin resistance, thinking skills, and other markers of health.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Sabroxy®
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Change in Inflammatory Biomarker (High-Sensitivity C-Reactive Protein, hs-CRP), Change in Montreal Cognitive Assessment (MoCA) Total Score
Neurology